Randomized trial assesses treatment effectiveness for non-effusive FIP in cats, suggesting management strategies for relapses.
GS-441524 and remdesivir are both effective treatment options for non-effusive FIP. However, further assessment of cats previously treated for non-effusive FIP is warranted to determine the rates of relapse and how best to manage them.
No takes yet. Share an insight, caveat, or question.
Brostoff et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: